Active	Status	Sponsor type	Region	Phase	Filter
1 Active 12 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Varadhachary, Gauri
UVA-PC-PD101, NCT02305186: Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer	Recruiting	1/2	68	US	Pembrolizumab, MK-3475, Keytruda, Neoadjuvant Chemoradiation	Craig L Slingluff, Jr	Pancreatic Cancer	12/22	12/22